Literature DB >> 25214993

Association of MMP-9 gene polymorphisms with acute coronary syndrome in the Uygur population of China.

Lei Wang1, Yi-Tong Ma1, Xiang Xie1, Yi-Ning Yang1, Zhen-Yan Fu1, Fen Liu1, Xiao-Mei Li1, Bang-Dang Chen1.   

Abstract

BACKGROUND: Matrix metalloproteinase-9 (MMP-9) plays a pivotal role in early atherosclerosis, vascular remodeling and development of atherosclerotic lesion. The potentially functional MMP-9 gene polymorphism may contribute to the susceptibility of acute coronary syndrome (ACS). This study aimed to investigate the association between two single nucleotide polymorphisms (-1562C>T, R279Q) of the MMP-9 gene in patients with ACS in the Uygur population of China.
METHODS: This case-control study was composed of 361 ACS patients and 432 control subjects, who had undergone coronary angiography. Among the ACS patients, 162 (44.9%) had single-vessel disease, 145 (40.2%) had two-vessel disease, and 54 (14.9%) had three-vessel disease. The genotypes of the two selected SNPs were determined by the method of polymerase chain reaction and restriction fragment length polymorphism (RFLP-PCR). The relationship between the polymorphism of the MMP-9 gene and the severity of coronary arterial stenosis was analyzed.
RESULTS: Analysis of the two SNPs showed that the frequency of CT and TT genotypes in patients with ACS was significantly higher than that in the control group (ACS vs. controls; CT+TT: 25.5% vs. 15.8%, P=0.001). And the -1562 gene allele (C/T) was significantly associated with acute coronary syndrome (ACS vs. controls; C allele: 85.7% vs. 91.5%, T allele: 14.3% vs. 8.5%, P<0.001). But the frequencies of CT+TT and CC genotypes were not statistically different among ACS patients with one, two and three or more significantly diseased vessels (P=0.55). The R279Q polymorphism site with regard to the association with ACS was not significant (P>0.05). The presence of CT or TT genotypes, assuming codominant effect of the T allele, was independently associated with increased risk of coronary artery disease when adjustment was made for age, body mass index, smoking, hypertension and diabetes mellitus [odds ratio=1.737 (95% confidence interval, 1.337-2.257), P=0.018].
CONCLUSIONS: MMP-9-1562C>T polymorphism is associated with the susceptibility to ACS in the Uygur population of China. However, this mutation apparently is not related to the severity of coronary arterial stenosis. Another SNP (R279Q) polymorphism of MMP-9 is not significantly associated with the risk of ACS.

Entities:  

Keywords:  Acute coronary syndrome; Gene polymorphism; Matrix metalloproteinase-9; Uygur

Year:  2011        PMID: 25214993      PMCID: PMC4129690          DOI: 10.5847/wjem.j.1920-8642.2011.02.005

Source DB:  PubMed          Journal:  World J Emerg Med        ISSN: 1920-8642


  33 in total

1.  Genetic variation at the matrix metalloproteinase-9 locus on chromosome 20q12.2-13.1.

Authors:  B Zhang; A Henney; P Eriksson; A Hamsten; H Watkins; S Ye
Journal:  Hum Genet       Date:  1999-11       Impact factor: 4.132

2.  An updated coronary risk profile. A statement for health professionals.

Authors:  K M Anderson; P W Wilson; P M Odell; W B Kannel
Journal:  Circulation       Date:  1991-01       Impact factor: 29.690

3.  Increased secretion of gelatinases A and B from the aortas of cholesterol fed rabbits: relationship to lesion severity.

Authors:  A B Zaltsman; A C Newby
Journal:  Atherosclerosis       Date:  1997-04       Impact factor: 5.162

4.  Increased matrix metalloproteinase-9 activity in unstable carotid plaques. A potential role in acute plaque disruption.

Authors:  I M Loftus; A R Naylor; S Goodall; M Crowther; L Jones; P R Bell; M M Thompson
Journal:  Stroke       Date:  2000-01       Impact factor: 7.914

5.  Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis.

Authors:  B Zhang; S Ye; S M Herrmann; P Eriksson; M de Maat; A Evans; D Arveiler; G Luc; F Cambien; A Hamsten; H Watkins; A M Henney
Journal:  Circulation       Date:  1999-04-13       Impact factor: 29.690

Review 6.  Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly.

Authors:  Zorina S Galis; Jaikirshan J Khatri
Journal:  Circ Res       Date:  2002-02-22       Impact factor: 17.367

Review 7.  Genetic diversity in the matrix metalloproteinase family. Effects on function and disease progression.

Authors:  A M Henney; S Ye; B Zhang; S Jormsjö; C Whatling; P Eriksson; A Hamsten
Journal:  Ann N Y Acad Sci       Date:  2000-05       Impact factor: 5.691

8.  Plasma levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 are increased in the coronary circulation in patients with acute coronary syndrome.

Authors:  Y Inokubo; H Hanada; H Ishizaka; T Fukushi; T Kamada; K Okumura
Journal:  Am Heart J       Date:  2001-02       Impact factor: 4.749

9.  Lipids, diabetes, and coronary heart disease: insights from the Framingham Study.

Authors:  W B Kannel
Journal:  Am Heart J       Date:  1985-11       Impact factor: 4.749

10.  Polymorphisms in the promoter regions of MMP-2, MMP-3, MMP-9 and MMP-12 genes as determinants of aneurysmal coronary artery disease.

Authors:  Nicolas Lamblin; Christophe Bauters; Xavier Hermant; Jean-Marc Lablanche; Nicole Helbecque; Philippe Amouyel
Journal:  J Am Coll Cardiol       Date:  2002-07-03       Impact factor: 24.094

View more
  5 in total

1.  Association and Prognostic Significance of the Functional -1562C/T Polymorphism in the Promoter Region of MMP-9 in Turkish Patients with Gastric Cancer.

Authors:  Nilufer Avcı; Mehmet Ture; Adem Deligonul; Erdem Cubukcu; Omer Fatih Olmez; Serdar Sahinturk; Ali Topak; Ender Kurt; Turkkan Evrensel; Ahmet Bilgehan Şahin; Tahsin Yakut
Journal:  Pathol Oncol Res       Date:  2015-07-09       Impact factor: 3.201

2.  High serum level of matrix metalloproteinase 9 and promoter polymorphism - 1562 C:T as a new risk factor for metabolic syndrome.

Authors:  Suraj S Yadav; Raju K Mandal; Manish K Singh; Archna Verma; Pradeep Dwivedi; Rishi Sethi; Kauser Usman; Sanjay Khattri
Journal:  DNA Cell Biol       Date:  2014-09-11       Impact factor: 3.311

3.  Evaluation of physiological risk factors, oxidant-antioxidant imbalance, proteolytic and genetic variations of matrix metalloproteinase-9 in patients with pressure ulcer.

Authors:  Khlifi Latifa; Sahli Sondess; Graiet Hajer; Ben-Hadj-Mohamed Manel; Khelil Souhir; Bouzidi Nadia; Jaballah Abir; Ferchichi Salima; Miled Abdelhedi
Journal:  Sci Rep       Date:  2016-07-11       Impact factor: 4.379

4.  Plasma concentration, genetic variation, and gene expression levels of matrix metalloproteinase 9 in Iranian patients with coronary artery disease.

Authors:  Khalil Mahmoodi; Koorosh Kamali; Elham Karami; Mohammad Soleiman Soltanpour
Journal:  J Res Med Sci       Date:  2017-01-27       Impact factor: 1.852

5.  Impact of matrix metalloproteinase 9 rs3918242 genetic variant on lipid-lowering efficacy of simvastatin therapy in Chinese patients with coronary heart disease.

Authors:  Yuanyuan Xu; Yan Wang; Jixin Zhi; Lichun Qi; Tong Zhang; Xueqi Li
Journal:  BMC Pharmacol Toxicol       Date:  2017-04-08       Impact factor: 2.483

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.